June 2022 FDA Recall Draximage Maa by Jubilant Draximage Inc
D-1189-2022 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Jubilant Draximage Inc on June 16, 2022 for the product Draximage Maa. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1189-2022

Reason for Recall
Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.
Initiated
06-16-2022
Reported
07-20-2022
Quantity
519 cartons/30 vials each

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Jubilant Draximage Inc
Product was distributed to retailers nationwide.
Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.

Batch or Lot Expiration Information

Lot# 1H005, exp. date Nov 30, 2023

Affected Packages Involved in this Recall